Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Digital Content
NEWS #PharmaBuzz
Market Place
APIs
Reply
25 Jul 2020
Reply
06 Jun 2019
Reply
25 Aug 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Selamectin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Selamectin manufacturer or Selamectin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Selamectin manufacturer or Selamectin supplier.
PharmaCompass also assists you with knowing the Selamectin API Price utilized in the formulation of products. Selamectin API Price is not always fixed or binding as the Selamectin Price is obtained through a variety of data sources. The Selamectin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A D05813 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D05813, including repackagers and relabelers. The FDA regulates D05813 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D05813 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of D05813 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A D05813 supplier is an individual or a company that provides D05813 active pharmaceutical ingredient (API) or D05813 finished formulations upon request. The D05813 suppliers may include D05813 API manufacturers, exporters, distributors and traders.
click here to find a list of D05813 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A D05813 CEP of the European Pharmacopoeia monograph is often referred to as a D05813 Certificate of Suitability (COS). The purpose of a D05813 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of D05813 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of D05813 to their clients by showing that a D05813 CEP has been issued for it. The manufacturer submits a D05813 CEP (COS) as part of the market authorization procedure, and it takes on the role of a D05813 CEP holder for the record. Additionally, the data presented in the D05813 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the D05813 DMF.
A D05813 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. D05813 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of D05813 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing D05813 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for D05813 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture D05813 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain D05813 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a D05813 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of D05813 suppliers with NDC on PharmaCompass.
D05813 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D05813 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D05813 GMP manufacturer or D05813 GMP API supplier for your needs.
A D05813 CoA (Certificate of Analysis) is a formal document that attests to D05813's compliance with D05813 specifications and serves as a tool for batch-level quality control.
D05813 CoA mostly includes findings from lab analyses of a specific batch. For each D05813 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D05813 may be tested according to a variety of international standards, such as European Pharmacopoeia (D05813 EP), D05813 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D05813 USP).
Comment (6)
